Iron Status in Children With ADHD
1 other identifier
observational
44
0 countries
N/A
Brief Summary
Evaluation of the status of iron deficiency in children with attention deficit hyperactivity disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJuly 17, 2024
July 1, 2024
1 year
July 9, 2024
July 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Iron status in children with attention deficit hyperactivity disorder
To determine number of patients with ADHD who have associated iron deficiency
Baseline
Interventions
diagnostic tests for iron status
Eligibility Criteria
All children above 4 years and under 12 years old diagnosed with attention deficit hyperactivity disorder (ADHD)
You may qualify if:
- All children above 4 years and under 12 years old diagnosed with attention deficit hyperactivity disorder (ADHD) according to DSM-V criteria.
- Not receiving iron therapy
You may not qualify if:
- Children under 4 years old
- Above 12 years old
- Not diagnosed attention deficit hyperactivity disorder(ADHD)
- Any other associated neurological disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Mantadakis E, Chatzimichael E, Zikidou P. Iron Deficiency Anemia in Children Residing in High and Low-Income Countries: Risk Factors, Prevention, Diagnosis and Therapy. Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020041. doi: 10.4084/MJHID.2020.041. eCollection 2020.
PMID: 32670519BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 9, 2024
First Posted
July 17, 2024
Study Start
September 1, 2024
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
July 17, 2024
Record last verified: 2024-07